LUCY
Innovative Eyewear, Inc.NASDAQHealthcare$1.06-3.64%ClosedMarket Cap: $4.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
1.59
EV/EBITDA
778.36
DCF Value
$1,703.36
FCF Yield
72501.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
21.3%
Operating Margin
-319.2%
Net Margin
-285.2%
ROE
-0.3%
ROA
-0.1%
ROIC
-0.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $959.8K | 12.0% | $-2.5M | $-1.9M | $-0.34 | — |
| FY 2025 | $2.7M | 21.3% | $-8.5M | $-7.6M | $-1.90 | — |
| Q3 2025 | $668.1K | 36.6% | $-1.9M | $-1.8M | $-0.38 | — |
| Q2 2025 | $579.2K | -2.2% | $-2.2M | $-2.1M | $-0.66 | — |
| Q1 2025 | $454.5K | 48.5% | $-1.9M | $-1.8M | $-0.72 | — |
| Q4 2024 | $690.7K | 13.6% | $-2.2M | $-2.1M | $-0.87 | — |
| FY 2024 | $1.6M | 13.1% | $-7.9M | $-7.8M | $-5.19 | — |
| Q3 2024 | $253.6K | 23.4% | $-1.8M | $-1.7M | $-0.99 | — |
| Q2 2024 | $308.7K | 17.9% | $-2.0M | $-1.9M | $-1.87 | — |
| Q1 2024 | $383.5K | 1.8% | $-2.0M | $-2.0M | $-3.04 | — |
| Q4 2023 | $615.8K | -29.3% | $-2.5M | $-2.4M | $-3.70 | — |
| FY 2023 | $1.2M | -10.4% | $-6.9M | $-6.7M | $-12.67 | — |